The agreements were signed on March 26, 2021, followed with a virtual ceremony that took place on April 7, 2021. The technologies were developed by ICAR-IVRI and the commercialization of the technologies was facilitated by Agrinnovate India, a company owned by Department of Agricultural, Research & Education (DARE), Ministry of Agriculture, Government of India.
Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection.
Classical Swine Fever Vaccine has been found to induce protective immunity up to 24 months. Sheep Pox Vaccine has been found to induce protective immunity up to 48 months. The vaccines hope to prevent economic losses in swine and sheep farming in India, company said.
It is Hester’s endeavour to produce good quality vaccines, at low cost in order to enable the immunisation of animals against these diseases. Hester has targeted to launch both the vaccines commercially in approximately 8 months.
The swine population in India is estimated to be 9.06 million (90 lacs). The sheep population in India is estimated to be 74.26 million (7.42 crores). With a focus on livestock as a source of income, the over-all population of swine and sheep is expected to grow rapidly thereby increasing the demand for vaccines.